Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Conditions: DM1; Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Dystrophy Type 1; Myotonic Dystrophy Type-1; Myotonic Dystrophy, Type 1 (DM1); Myotonic Muscular Dystrophy
Sponsors: Virginia Commonwealth University; Dyne Therapeutics; Myotonic Dystrophy Clinical Research Network (DMCRN)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 14, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments